AKTX

Akari Therapeutics
AKTX

21 hedge funds and large institutions have $16.8M invested in Akari Therapeutics in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.96M
2
+$1.29M
3
+$871K
4
BBA
Baker Bros. Advisors
New York
+$866K
5
Millennium Management
Millennium Management
New York
+$626K

Top Sellers

1
-$796K
2
-$39K
3
-$8.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.02M
2
$2.96M
3
$1.96M
4
$1.85M
5
$1.5M
6
$1.29M
7
$1.13M
8
$1.08M
9
$871K
10
$655K
11
$159K
12
$130K
13
$114K
14
$35K
15
$32K
16
$13K
17
$4K
18
$1K
19
$1K